A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus Infection

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus Infection	Chronic Hepatitis D Infection	Not yet recruiting	Phase 2	2026-08-13		NCT07762027

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Assembly Biosciences	2

22 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Aga Khan University Hospital	Karachi	Pakistan	4
AP-HP - Beaujon Hospital	Clichy	France	1
ARENSIA Exploratory Medicine Ivano-Frankivsk	Ivano-Frankivsk	Ukraine	1
Arensia Research Clinic	Bucharest	Romania	1
Azienda Ospedaliera Universitaria	Naples	Italy	1
CHU Lyon - Hôpital Croix-Rousse	Lyon	France	1
Clinical Republican Hospital	Chisinau	Moldova	1
Dr. Victor Babes Foundation	Bucharest	Romania	1
Dr. Ziauddin Hospital	Karachi	Pakistan	1
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico	Milan	Italy	3
Fundeni Clinical Institute	Bucharest	Romania	4
Hospital Clínico Universitario Lozano Blesa	Zaragoza	Spain	11
Hôpital Henri-Mondor	Créteil	France	3
King's College Hospital London	London	United Kingdom	2
LLC Neolab	Tbilisi	Georgia	1
Medical Center of LLC ARENSIA Exploratory Medicine	Kyiv	Ukraine	1
Medizinische Hochschule Hannover	Hanover	Germany	42
New Zealand Clinical Research	Auckland	New Zealand	6
North Manchester General Hospital	Manchester	United Kingdom	4
Prof. Dr. Matei Bals National Institute of Infectious Diseases	Bucharest	Romania	1
The Royal London Hospital	London	United Kingdom	4
Universitätsklinikum Hamburg-Eppendorf	Hamburg	Germany	31

Clinical trials